Possible site of action of CGRP antagonists in migraine (Q34169056)

31 July 2017

1 reference

title

Possible site of action of CGRP antagonists in migraine (English)

1 reference

calcitonin gene-related peptide receptor antagonist

31 July 2017

0 references

0 references

2

Jes Olesen

0 references

Peer Carsten Tfelt-Hansen

series ordinal

1

object named as

Peer Tfelt-Hansen

1 reference

PubMed ID

21383046

31 July 2017

language of work or name

English

0 references

publication date

7 March 2011

1 reference

31 July 2017

1 reference

31 July 2017

31

1 reference

31 July 2017

748-750

1 reference

31 July 2017

6

1 reference

Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus

31 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Origin of pain in migraine: evidence for peripheral sensitisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

CGRP blockers in migraine therapy: where do they act?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

BIBN4096BS and CGRP(8-37) antagonize the relaxant effects of alpha-CGRP more than those of beta-CGRP in human extracranial arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Randomized, controlled trial of telcagepant for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

CGRP receptor antagonism and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411398403

21 January 2018

Identifiers

DOI

10.1177/0333102411398403

1 reference

31 July 2017

1 reference

PubMed ID

21383046